Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Medicine (2)
Nature Metabolism (2)
Nature Communications (1)
Scientific Reports (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (5)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Computational biology and bioinformatics
Diseases
Gastroenterology
Genetics
Immunology
Mathematics and computing
Medical research
Microbiology
Physiology
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–6 of 6 results

Advanced filters: Author: Amir Ben-Tov Clear advanced filters

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

The duration of effectiveness of SARS-CoV-2 vaccination is not yet known. Here, the authors present preliminary evidence of BNT162b2 vaccine waning across all age groups above 16, with a higher incidence of infection in people who received their second dose early in 2021 compared to later in the year.

Barak Mizrahi
Roni Lotan
Tal Patalon
ResearchOpen Access04 Nov 2021
Nature Communications

Volume: 12, P: 1-5
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals

New data from a large healthcare organization in Israel reveal a reduction in new infections in an unvaccinated population in communities with rapid vaccination rollouts, suggesting that mass vaccination strategies confer cross-protection of unvaccinated individuals.

Oren Milman
Idan Yelin
Roy Kishony
Research10 Jun 2021
Nature Medicine

Volume: 27, P: 1367-1369
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

Breakthrough infections of SARS-CoV-2 occurring 12 or more days after the first dose of the BNT162b2 mRNA vaccine were associated with lower viral loads than those found in unvaccinated individuals, suggesting that the vaccine might reduce infectiousness.

Matan Levine-Tiefenbrun
Idan Yelin
Roy Kishony
Research29 Mar 2021
Nature Medicine

Volume: 27, P: 790-792
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response

Lim, Adler et al. show that the urea cycle enzyme ASS1 can function in the nucleus to supply fumarate necessary to drive DNA damage responses.

Lisha Qiu Jin Lim
Lital Adler
Ayelet Erez
ResearchOpen Access10 Jun 2024
Nature Metabolism

Volume: 6, P: 1294-1309
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response

Lisha Qiu Jin Lim
Lital Adler
Ayelet Erez
Amendments and CorrectionsOpen Access04 Jul 2024
Nature Metabolism

Volume: 6, P: 1417
A machine learning tool for early identification of celiac disease autoimmunity

Michael Dreyfuss
Benjamin Getz
Amir Ben-Tov
ResearchOpen Access28 Dec 2024
Scientific Reports

Volume: 14, P: 1-9